PTPA and myeloproliferative disorder: Consistent with the data obtained with OA, more selective PP2A inhibitor LB-100 [28] also prevented ruxolitinib-induced autophagy (Supplementary Figures 3E,F) and increased the effect of ruxolitinib on the number of erythroid clones in MPN patients’samples (Supplementary Figure 3G).